How the new coronavirus stacks up against SARS and MERS

Coronaviruses, one of a variety of
viruses that cause colds, have been making people cough and sneeze seemingly
forever. But occasionally, a new version infects people and causes serious
illness and deaths.

That is happening now with the coronavirus that has killed at least 26 people and sickened at least 900 since it emerged in central China in December. The World Health Organization is monitoring the virus’s spread to see whether it will turn into a global public health emergency (SN: 1/23/20).

Among the ill are two people in the
United States who contracted the virus during travels in China. A Chicago woman
in her 60s is the second U.S. case of the new coronavirus, the Centers for
Disease Control and Prevention confirmed January 24 in a news conference.

Officials are currently monitoring 63
people across 22 states for signs of the pneumonia-like disease, including
fever, cough and other respiratory symptoms. Of those people, 11 have tested
negative for the virus. Two, including the newest case and another
patient in Seattle
, tested positive, the CDC reported (SN: 1/21/20).

France reported two cases on January 24
as well, the first in Europe.

Much still remains unknown about the new coronavirus (SN: 1/10/20), which for now is being called 2019 novel coronavirus, or 2019-nCoV.  Lessons learned from previous coronavirus outbreaks, including severe acute respiratory syndrome, or SARS, and Middle East respiratory syndrome, or MERS, may help health officials head off some of the more serious consequences from this virus outbreak.

What are coronaviruses?

Coronaviruses are round and surrounded
by a halo of spiky proteins, giving them a resemblance to a crown or the sun’s
wispy corona.

Four major categories, or genera, of
coronavirus exist. They’re known by the Greek letters alpha, beta, delta and
gamma. Only alpha and beta coronaviruses are known to infect people. These
viruses spread through the air, and just four types (known as 229E, NL63, OC43
and HKU1) are responsible for about 10 to 30 percent of colds around the world.

What makes a virus a coronavirus is only
loosely enshrined in its DNA. “The coronavirus designation is less about the
genetics and more about the way it appears under a microscope,” says Brent C.
Satterfield, cofounder and chief scientific officer of Co-Diagnostics, a
company based in Salt Lake City and Gujarat, India, that is developing
molecular tests for diagnosing coronavirus infections.

Coronaviruses’ genetic makeup is
composed of RNA, a single-stranded chemical cousin of DNA. Viruses in the
family often aren’t very similar on the genetic level, with some types having
more differences between them than humans have from elephants, Satterfield

The new virus’s proteins are between 70
and 99 percent identical to their counterparts in the SARS virus, says Karla
Satchell, a microbiologist and immunologist at Northwestern University Feinberg
School of Medicine in Chicago.

similar amino acids in coronavirus protein
A new coronavirus spreading in China is similar to SARS, but many of its proteins have important differences. Here, the new virus’s similarities (gray) and differences (red) with SARS of the amino acids in a protein that studs the surface of the viruses are shown in two views. Those differences may affect the viruses’ infectivity and how well drugs developed to combat other coronaviruses work against the new one.Courtesy of GISAID Initiative

How dangerous is a coronavirus infection?

Usually coronavirus illnesses are fairly mild, affecting just the upper airway. But the new virus, as well as both SARS and MERS, are different.

Those three types of betacoronaviruses
can latch onto proteins studding the outside of lung cells, and penetrate much
deeper into the airway than cold-causing coronaviruses, says Anthony Fauci,
director of the U.S. National Institute of Allergy and Infectious Diseases in
Bethesda, M.D. The 2019 version is “a disease that causes more lung disease
than sniffles,” Fauci says.

Damage to the lungs can make the viruses
deadly. In 2003 and 2004, SARS killed nearly 10 percent of the 8,096 people in
29 countries who fell ill. A total of 774 people died, according to the World
Health Organization.

MERS is even more deadly, claiming about
30 percent of people it infects. Unlike SARS, outbreaks of that virus are still
simmering, Fauci says. Since 2012, MERS has caused 2,494 confirmed cases in 27
countries and killed 858 people.

MERS can spread from person to person,
and some “superspreaders” have passed the virus on to many others. Most
famously, 186 people contracted MERS after one businessman unwittingly brought
the virus to South Korea in 2015 and spread it to others. Another superspreader
who caught MERS from that man passed
the virus to 82 people
over just two days while being treated in a hospital
emergency room (SN: 7/8/16).

Right now, 2019-nCoV appears to be less virulent, with about a 4 percent mortality rate. But that number is still a moving target as more cases are diagnosed, Fauci says. As of January 23, the new coronavirus had infected more than 581 people, with about a quarter of those becoming seriously ill, according to the WHO. By January 24, the number of reported infections had risen to at least 900.

An analysis of the illness in the first
41 patients diagnosed with 2019-nCoV from Wuhan, China suggests that the virus
acts similarly to SARS and MERS. Like the other two, 2019-nCoV causes
pneumonia. But unlike those viruses, the new one rarely
produces runny noses or intestinal symptoms
, researchers report January 24
in the Lancet. Most of the people
affected in that first group were healthy, with fewer than a third having
chronic medical conditions that could make them more vulnerable to infection.

Where do new coronaviruses come from?

Coronaviruses are zoonotic, meaning they
originate in animals and sometimes leap to humans. The first 2019-nCoV infections
detected in December were in patients who had visited the Huanan seafood market
in Wuhan. The market was closed January 1, but health officials have yet to
determine from which type of animal the virus jumped to humans.

Bats are often thought of as a source of
coronaviruses, but in most cases they don’t pass the virus directly on to
humans. SARS probably first jumped from bats into raccoon dogs or palm civets
before making the leap to humans. All the pieces necessary to re-create SARS
are circulating
among bats
, though that virus has not been seen since 2004 (SN: 11/30/17).

MERS, meanwhile, went
from bats to camels
before leaping to humans (SN: 2/25/14). A paper published January 22 in the Journal of Medical Virology suggests
that the new coronavirus has components from bat coronaviruses, but that snakes may have
passed the virus to humans
. But many virologists are
skeptical that snakes are behind the outbreak
(SN: 1/24/20).

How contagious are coronaviruses?

It depends on the coronavirus, but
neither SARS or MERS have been able to sustain human-to-human transmission the
way influenza viruses can, Fauci says. That’s because the viruses haven’t fully
adapted to infect humans, “and maybe they never will,” he says.

Still, “this is a family of viruses that
was formerly just the common cold,” he says. “But now, in the last 18 years,
we’ve had three examples of it jumping species and causing serious disease in
humans.” He and colleagues wrote an article published
January 23 in JAMA
to illustrate what
they see as the growing threat from coronaviruses.

In Wuhan, the new coronavirus has been
able to transmit down a chain of up to four people, health officials said. Five
members of a family from Shenzhen, China caught the virus
when they visited
infected relatives in Wuhan, researchers report January 24 in the Lancet. Travelers have also carried the
virus from China to at least seven other countries, including the United
States. No human-to-human transmission has yet been reported outside of China,
the WHO said. All of the deaths have also been in that country.

Epidemiologists are frantically
calculating how infectious the new virus is, says Maimuna Majumder, a
computational epidemiologist at Boston Children’s Hospital and Harvard Medical

The number that describes how many
people a newly infected person is likely to pass a virus to is called R0,
pronounced R
(SN: 5/28/19). SARS, for
instance, had an R0 between two and five, meaning that in a fully
susceptible population an infected person could potentially spread the virus to
two to five others. (Highly contagious measles, in comparison, has a R0
from 12 to 18.)

Estimates for the infectivity of the new
virus range from the WHO’s estimate of 1.4 to 2.5 to a much bigger 3.6 to 4.0
calculation from Jonathan Read of Lancaster University in England and
colleagues. Read’s group estimates that only about
5.1 percent of cases in Wuhan have been identified
. The researchers
reported the preliminary results January 24 at

That’s probably not because the Chinese
government is covering up how bad the outbreak is, Majumder says. Many people
may have had only mild symptoms or none at all. Those people probably wouldn’t
go to the doctor and get tested for the virus.

Majumder and Harvard colleague Kenneth
Mandl used a different method to calculate R0 for the new virus,
estimating based on cases reported as of January 22 that its transmissibility
falls from
2.0 to 3.3
. Their results were posted to SSRN on January 23.

Meanwhile, Christian Althaus and Julien
Riou, both of the University of Bern in Switzerland, posted data to Github
supporting their calculation that the new virus’s infectivity is between 1.4 and 3.8. Each of those
calculations was arrived at using different methods. While they are slightly
different, they overlap, and Majumder says she’s reassured that the numbers are

Similar infectivity to SARS doesn’t mean
the new virus will spread like that one did.

“Having SARS in [our] history can help
inform some these decisions that we’re going to make now. Back then, we were
less prepared than we are now,” Majumder says.

What treatments are available?

For now, all doctors can do is treat
symptoms of the new disease. Researchers have also developed some experimental
treatments based on SARS and MERS, including antibodies that may help combat
the infections, Fauci says.

Getting samples of the new virus may
allow researchers to develop “monoclonal” antibodies in the lab. Or scientists
may be able to take immune B cells from people who already have recovered from
the virus to produce antibodies to help other infected people.

Some antiviral medications have shown promise in treating MERS, and are being tested for their effectiveness against 2019-nCoV. Experimental vaccines, Facui wrote in JAMA, including some based on RNA, are also in the works.

Erin Garcia de Jesus contributed to reporting of this story.